Viridian Therapeutics, Inc. (VRDN) vs GeneDx Holdings Corp. (WGS)
A side-by-side comparison of Viridian Therapeutics, Inc. and GeneDx Holdings Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
VRDN
Viridian Therapeutics, Inc.
$18.22HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
WGS
GeneDx Holdings Corp.
$71.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — VRDN vs WGS
growth of $100 · dividends reinvested · last 6yVRDN -1.8% (-0.3%/yr)WGS -76.4% (-21.4%/yr)VRDN compounded faster over this window
VRDN WGS
VRDN vs WGS: by the numbers
- •WGS is the larger company ($2.13B vs $2.06B market cap).
- •Both run net losses; WGS's is the smaller (-23.40% vs -544.06% net margin).
- •VRDN grew revenue faster over the past five years (93.92% vs 16.28% CAGR).
Metrics side by side
Valuation
| Metric | VRDN | WGS |
|---|---|---|
| P/S ratio | 29.02 | 4.69 |
| P/B ratio | 3.66 | 8.73 |
Profitability
| Metric | VRDN | WGS |
|---|---|---|
| Gross margin | 99.55% | 68.20% |
| Operating margin | -512.91% | -2.76% |
| Net margin | -544.06% | -23.40% |
| ROE | -58.45% | -43.55% |
| ROIC | -39.18% | -14.69% |
Growth (annualized)
| Metric | VRDN | WGS |
|---|---|---|
| Revenue CAGR (5Y) | 93.92% | 16.28% |
| Total return CAGR (5Y) | 1.64% | -19.67% |
Frequently asked
- Which has grown faster, VRDN or WGS?
- Over the past five years, VRDN grew revenue faster — VRDN at a 93.92% CAGR versus WGS at 16.28%.
- How have VRDN and WGS total returns compared?
- Over the past 5 years, VRDN delivered 1.64% and WGS delivered -19.67% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Viridian Therapeutics ROEGeneDx ROEViridian Therapeutics operating marginGeneDx operating marginViridian Therapeutics revenue growthGeneDx revenue growthViridian Therapeutics free cash flowGeneDx free cash flow
Viridian Therapeutics & GeneDx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.